CVS Health Co. (NYSE:CVS - Get Free Report)'s share price was up 1.5% during trading on Monday . The stock traded as high as $52.89 and last traded at $52.72. Approximately 13,362,187 shares were traded during mid-day trading, a decline of 2% from the average daily volume of 13,670,579 shares. The stock had previously closed at $51.96.
Analyst Ratings Changes
Several research firms have weighed in on CVS. Piper Sandler lowered their target price on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. UBS Group lifted their target price on shares of CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research note on Thursday, November 7th. Royal Bank of Canada dropped their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. StockNews.com cut CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday, November 14th. Finally, Wells Fargo & Company raised CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $68.71.
Read Our Latest Stock Analysis on CVS Health
CVS Health Stock Performance
The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The firm has a 50 day moving average of $51.34 and a two-hundred day moving average of $56.32. The stock has a market cap of $66.35 billion, a P/E ratio of 13.38, a P/E/G ratio of 0.72 and a beta of 0.59.
CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health's quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.21 earnings per share. On average, research analysts predict that CVS Health Co. will post 5.22 EPS for the current fiscal year.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.05%. CVS Health's payout ratio is presently 67.51%.
Institutional Trading of CVS Health
Large investors have recently bought and sold shares of the stock. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth about $25,000. Ridgewood Investments LLC grew its stake in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after buying an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the third quarter worth approximately $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health in the third quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter worth approximately $32,000. 80.66% of the stock is currently owned by institutional investors.
About CVS Health
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
